Clinical trial
A Cross-sectional Study on Iodine Status and Characteristics of Papillary Thyroid Cancer
NCT06626581 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cross-sectional Study on Iodine Status and Characteristics of Papillary Thyroid Cancer
- Lead sponsor
- Shandong Provincial Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 600 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
papillary thyroid carcinoma